Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiracoxib vs Diclofenac in CKD Stage III
NCT01481610Phase 2Terminated
- Sponsor
- Hospital Central Sur de Alta Especialidad
- Start
- Jan 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lumiracoxib in arthralgia, sponsored by Hospital Central Sur de Alta Especialidad. Started Jan 2012; status: terminated.
02
Drugs
lumiracoxib
03
Conditions
arthralgia
Beyond the preview
Go deeper on NCT01481610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481610.